| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $103.9M | +29.2% |
| Cost of Revenue | $44.6M | -4.3% |
| Gross Profit | $59.3M | +75.3% |
| R&D Expense | $23.4M | -4.1% |
| SG&A Expense | $56.6M | +34.6% |
| Operating Income | -$82.3M | +6.7% |
| Pre-tax Income | -$54.0M | +49.1% |
| Income Tax | $0 | -100.0% |
| Net Income | -$54.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.0M | -44.9% |
| Short-term Investments | $14.9M | -70.9% |
| Accounts Receivable | $28.4M | +25.6% |
| Inventory | $17.0M | +78.4% |
| Current Assets | $121.4M | -30.9% |
| Total Assets | $268.1M | -10.3% |
| Current Liabilities | $96.7M | +17.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.9M | -214.8% |
| Investing Cash Flow | -$1.4M | +98.9% |
| Financing Cash Flow | $1.8M | +106.1% |
| +49.2% |
| EPS (Basic) | -$0.34 | +52.1% |
| EPS (Diluted) | -$0.34 | +52.1% |
| Long-term Debt |
| $19.7M |
| — |
| Total Liabilities | $150.4M | -1.3% |
| Stockholders' Equity | $117.7M | -19.6% |